Filing Details
- Accession Number:
- 0001373894-19-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-13 15:48:35
- Reporting Period:
- 2019-03-11
- Accepted Time:
- 2019-03-13 15:48:35
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 806517 | Psychemedics Corp | PMD | Services-Medical Laboratories (8071) | 581701987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1505148 | Neil Lerner | C/O Psychemedics Corporation 289 Great Road, Suite 200 Acton MA 01720 | Vp - Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $.005 Par Value | Disposition | 2019-03-11 | 7,645 | $15.11 | 14,632 | No | 4 | S | Direct | |
| Common Stock, $.005 Par Value | Disposition | 2019-03-12 | 1,412 | $15.06 | 13,220 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.30, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
- The Price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $14.93 to $15.25, inclusive. The reporting person undertakes to provide Psychemedics Corporation, any security holder of Psychemedics Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
Billionaire Hedge Funds
